SPY332.37-1.82 -0.54%
DIA274.42-1.48 -0.54%
IXIC11,085.25-32.28 -0.29%

Bio-Path shares are trading lower as a potential sell-off after the stock increased roughly 25% on Friday's trading session. HC Wainwright & Co lowered its price targets from $18 to $12 per share.

Benzinga · 08/17/2020 16:50